{{header
 | author     = Steve Israel
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2014
 | month      = 06
 | day        = 02
 | notes      = ''{{USBill|113|H.R.|4798}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 2
 | title      = United States-Israel Alzheimer’s Disease Cooperation Act ( H.R. 4798; 113th Congress)
 | bill       = 4798
 | billtype   = hr
 | purpose    = To authorize the Secretary of Health and Human Services to award grants for Alzheimer’s disease research.
 | wikipedia  =
}}
      
{{Center|113th CONGRESS}}

 
{{Center|2d Session}}

 
{{Center|H. R. 4798}}

 
{{Center|IN THE HOUSE OF REPRESENTATIVES}}

  
{{Center|June 2, 2014}}

 
{{Center| 
[[w:Steve Israel|Mr. Israel]]introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] }}

  
{{Center|A BILL}}

 To authorize the Secretary of Health and Human Services to award grants for Alzheimer’s disease research.   

=Section 1. Short title=

This Act may be cited as the“   United States-Israel Alzheimer’s Disease Cooperation Act   ”. 

=Sec. 2. Findings=

The [[w:United States Congress|Congress]]finds the following:
:(1) It is in the highest national interests of the United States to further research into Alzheimer’s disease.
:(2) The State of Israel is a steadfast ally of the United States.
:(3) The special relationship between the United States and Israel is manifested in a variety of cooperative scientific research and development programs, such as—
::(A) the United States-Israel Binational Science Foundation;
::(B) the United States-Israel Binational Industrial Research and Development Foundation; and
::(C) the United States-Israel Energy Cooperation Act.
:(4) Those programs have made possible many scientific, technological, and commercial breakthroughs in fields including the life sciences, medicine, bioengineering, agriculture, biotechnology, communications, and energy development.
:(5) Israeli scientists are at the forefront of research and development in the field of Alzheimer’s disease.
:(6) Enhanced cooperation between the United States and Israel for the purpose of research in Alzheimer’s disease would be in the national interests of both countries. 

=Sec. 3. Grants for Alzheimer’s disease research=



==(a) Grant program– ==



===(1) Establishment– ===

The [[w:Department of Health and Human Services|Secretary of Health and Human Services]](in this section referred to as the“Secretary”) shall establish a program of awarding grants to support research on the development and commercialization of applicable tools, treatments, and cures for Alzheimer's disease and other dementias.

===(2) Eligible projects– ===

To be eligible for funding under this section, a project shall—
:(A) be designed to further research described in paragraph (1) ; and
:(B) be a joint venture between—
::(i) 
:::(I) a for-profit business entity, academic institution, National Laboratory (as defined in  section 2 of the Energy Policy Act of 2005 ( [http://www.law.cornell.edu/uscode/text/42/15801 42 U.S.C. 15801] )), or nonprofit entity in the United States; and
:::(II) a for-profit business entity, academic institution, or nonprofit entity in Israel; or
::(ii) 
:::(I) the Federal Government; and
:::(II) the Government of Israel.

===(3) Applications– ===

To seek a grant under this section, an applicant shall submit to the [[w:Department of Health and Human Services|Secretary]]an application in accordance with procedures established by the [[w:Department of Health and Human Services|Secretary,]]in consultation with the advisory board established under paragraph (4) .

===(4) Advisory board– ===



====(A) Establishment– ====

The [[w:Department of Health and Human Services|Secretary]]shall establish an advisory board—
:(i) to monitor the method by which grants are awarded under this section; and
:(ii) to provide to the [[w:Department of Health and Human Services|Secretary]]periodic performance reviews of actions taken to carry out this section.

====(B) Composition– ====

The advisory board established under subparagraph (A) shall be composed of 3 members, to be appointed by the [[w:Department of Health and Human Services|Secretary]], of whom—
:(i) 1 shall be a representative of the Federal Government;
:(ii) 1 shall be selected from a list of nominees provided by the United States-Israel Binational Science Foundation; and
:(iii) 1 shall be selected from a list of nominees provided by the United States-Israel Binational Industrial Research and Development Foundation.

===(5) Contributed funds– ===

Notwithstanding[http://www.law.cornell.edu/uscode/text/31/3302  section 3302of title 31, United States Code], the [[w:Department of Health and Human Services|Secretary]]may accept, retain, and use funds contributed by any person, government entity, or organization for purposes of carrying out this section—
:(A) without further appropriation; and
:(B) without fiscal year limitation.

===(6) Report– ===

Not later than 180 days after the date of completion of a project for which a grant is provided under this section, the grant recipient shall submit to the [[w:Department of Health and Human Services|Secretary]]a report that contains—
:(A) a description of the method by which the recipient used the grant funds; and
:(B) an evaluation of the level of success of each project funded by the grant.

===(7) Classification– ===

Grants shall be awarded under this section only for projects that are considered to be unclassified by both the United States and Israel.

==(b) Termination– ==

The grant program and the advisory committee established under this section terminate on the date that is 7 years after the date of enactment of this Act.

==(c) Authorization of appropriations– ==

 There is authorized to be appropriatedto carry out this section    $3,000,000 for the period of fiscal years 2015 through 2021. Any amounts appropriated pursuant to this subsection shall be in addition to amounts accepted, retained, and used pursuant to subsection (a)(5) .   
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
